Meeting Thu, 09/15/2022 - 12:00 Drug Prior Authorization Committee Meeting Information

Date
Media
Edit Implementation Schedule September 2022
PDL Announcement September 2022
PDL Recommendations September 2022
New Drugs Edits September 2022
Conduent Reports September 2022
Agenda
Agenda September 2022
Minutes
Minutes September 2022
Criteria
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
Entresto September 2022
Spinal Muscular Atrophy September 2022
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
Alpelisib September 2022
ATTR September 2022
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
ACEI Diuretic Combos September 2022
ACEI CCB Combos September 2022
ADHD Methylphenidate SA September 2022
ADHD Non Stimulants September 2022
Alpha Glucosidase Inhibitors September 2022
Amylin Analogs September 2022
Antibiotics Mupirocin Topical September 2022
Antihyperuricemic Agents September 2022
ARB Diuretic Combos September 2022
ARB CCB Combos September 2022
BB Diuretic Combos September 2022
Benign Prostatic Hyperplasia Agents September 2022
Biguanides and Combos September 2022
Bone Ossification Agents September 2022
CCB Non DHP September 2022
Cephalosporins September 2022
Direct Renin Inhibitors and Combos September 2022
DPPIV Inhibitors September 2022
Electrolyte Depleting Agents Phosphate Lowering September 2022
Erythropoiesis Stimulating Agents September 2022
Fluoroquinolones Oral September 2022
Homozygous Familial Hypercholesterolemia September 2022
Insulin Mixed September 2022
Insulin Non Analogs September 2022
Insulin Rapid Acting September 2022
Macrolides September 2022
Meglitinides September 2022
Methotrexate September 2022
Niacin Derivatives September 2022
PAH ETRAs September 2022
PAH PDE5 SGC September 2022
PAH Prostacyclins Oral September 2022
Penicillins September 2022
SGLT2 Inhibitors September 2022
Statins and Combos September 2022
Sulfonylurea Agents Second Generation September 2022
Tetracyclines September 2022
Thiazolidinediones and Combos September 2022
Thrombocytopenia Agents September 2022
Triglyceride Lowering Agents September 2022
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
ADHD Amphetamines Long Active September 2022
ADHD Amphetamines Short Acting September 2022
ADHD Methylphenidate Long Acting September 2022
Antibiotics GI Oral September 2022
Antibiotics Vaginal September 2022
Anticoagulants Oral and Subcutaneous September 2022
Anticonvulsants Rescue Agents September 2022
Antiplatelet Agents September 2022
Bile Salt Agents September 2022
CCB DHP September 2022
Colony Stimulating Factors September 2022
Cryopyrin Associated Periodic Syndrome September 2022
Dry Eye Disease Agents September 2022
Electrolyte Depleting Agents Potassium Lowering September 2022
GLP1 Receptor Agonists and Combos September 2022
Growth Hormone Agents Somatropin September 2022
Growth Hormone and Releasing Factors September 2022
Insulin Long Acting September 2022
LHRH GnRH Agents Non Oral September 2022
LHRH GnRH Agents Oral September 2022
Multiple Sclerosis Agents Injectable September 2022
Multiple Sclerosis Agents Oral September 2022
PAH Prostacyclins Inhaled September 2022
PAH Prostacyclins Injectable September 2022
PCSK9 Inhibitors September 2022
Proton Pump Inhibitors September 2022
Sympatholytics September 2022
Targeted Immune Modulators JAK Inhibitors September 2022
Targeted Immune Modulators IL6 Receptor Inhibitor September 2022
Targeted Immune Modulators IL17 Receptor Antagonists September 2022
Targeted Immune Modulators IL23 12 Inhibitors September 2022
Targeted Immune Modulators Misc Allergy and Asthma Related Monoclonal Antibodies September 2022
Targeted Immune Modulators Select Agents September 2022
Targeted Immune Modulators TNF Inhibitors September 2022
Urinary Tract Antispasmodics September 2022
Page
Drug Prior Authorization Committee Meeting Information